agilon health Reports Q2 2026 Financial Results

What Happened
On August 5, 2026, agilon health, inc. announced its financial results for the three and six months ended June 30, 2026 by issuing a press release. The press release was furnished as Exhibit 99.1 to a Form 8-K (Item 2.02: Results of Operations and Financial Condition) filed that day and the filing was signed by CFO Jeffrey Schwaneke.

Key Details

• Form 8-K filed on August 5, 2026 under Item 2.02 (Results of Operations and Financial Condition).
• Results cover the three- and six-month periods ended June 30, 2026.
• Press release is furnished as Exhibit 99.1 to the Form 8-K.
• Filing executed/signed by Jeffrey Schwaneke, Chief Financial Officer.

Why It Matters
This 8-K notifies investors that agilon has publicly released its Q2 2026 quarterly results—information investors use to evaluate recent revenue, profit/loss, cash flow and operating trends. The press release itself (Exhibit 99.1) will contain the specific figures and metrics that can affect the company’s near-term outlook and stock performance. The filing is limited to the earnings release; no other material events were disclosed in this Form 8-K.